Irreversible photolabeling of active site of neutral endopeptidase-24.11 enkephalinase by azidothiorphan and [14C]-azidothiorphan

Azidothiorphan and its (/sup 14/C)-labeled analogue have been developed as photoaffinity ligands for the active site of the neutral endopeptidase 24.11. In in vitro assays azidothiorphan inhibits the endopeptidase activity with a Ki of 0.75 nM. After ultraviolet irradiation the inhibitor binds irreversibly to the enzyme, and many factors suggest that the photolabeling occurs at the active site. The binding is accompanied by a loss of enzymatic activity, and the inclusion of the competitive inhibitor thiorphan protects the endopeptidase from this inactivation. In addition the binding of another competitive inhibitor (/sup 3/H)N-((R,S)-3-hydroxyaminocarbonyl-2-benzyl-1-oxopropyl)-glycine to the active site of endopeptidase-24.11 is inhibited after irradiation with azidothiorphan. Experiments with (/sup 14/C)-azidothiorphan have shown that very little nonspecific binding of inhibitor to enzyme occurs and the the labeled probe remains bound under denaturing conditions. Azidothiorphan has also been found to produce a long-lasting naloxone-reversible analgesia after intracerebroventricular administration. The results show that azidothiorphan should prove useful both for structural studies and for investigations on the synthesis and turnover of the neutral endopeptidase-24.11.